Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2032?

Resolution rules

If the FDA approves midomafetamine / MDMA for PTSD for marketing before Jan 1, 2032, then the market resolves to Yes.

Research this market

Inspect the YES and NO price history, spread and public order book in the terminal. Lab strategies can be tested over the available visible price history. Model overlays require a linked game and available model data.

More markets to explore